pubmed-article:17894765 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17894765 | lifeskim:mentions | umls-concept:C0015000 | lld:lifeskim |
pubmed-article:17894765 | lifeskim:mentions | umls-concept:C0879626 | lld:lifeskim |
pubmed-article:17894765 | lifeskim:mentions | umls-concept:C1306577 | lld:lifeskim |
pubmed-article:17894765 | lifeskim:mentions | umls-concept:C1280477 | lld:lifeskim |
pubmed-article:17894765 | lifeskim:mentions | umls-concept:C0920425 | lld:lifeskim |
pubmed-article:17894765 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
pubmed-article:17894765 | lifeskim:mentions | umls-concept:C0206012 | lld:lifeskim |
pubmed-article:17894765 | lifeskim:mentions | umls-concept:C2346845 | lld:lifeskim |
pubmed-article:17894765 | lifeskim:mentions | umls-concept:C0205540 | lld:lifeskim |
pubmed-article:17894765 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:17894765 | pubmed:dateCreated | 2007-9-26 | lld:pubmed |
pubmed-article:17894765 | pubmed:abstractText | As cancer survival is improving approximately by 1-2% per year, delays in the clinical trials that lead to that improvement could cost lives. | lld:pubmed |
pubmed-article:17894765 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17894765 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17894765 | pubmed:language | eng | lld:pubmed |
pubmed-article:17894765 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17894765 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17894765 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17894765 | pubmed:month | Oct | lld:pubmed |
pubmed-article:17894765 | pubmed:issn | 1445-5994 | lld:pubmed |
pubmed-article:17894765 | pubmed:author | pubmed-author:DeasJJ | lld:pubmed |
pubmed-article:17894765 | pubmed:author | pubmed-author:GabrielG SGS | lld:pubmed |
pubmed-article:17894765 | pubmed:author | pubmed-author:ChristieD R... | lld:pubmed |
pubmed-article:17894765 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:17894765 | pubmed:volume | 37 | lld:pubmed |
pubmed-article:17894765 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17894765 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17894765 | pubmed:pagination | 680-6 | lld:pubmed |
pubmed-article:17894765 | pubmed:dateRevised | 2008-5-27 | lld:pubmed |
pubmed-article:17894765 | pubmed:meshHeading | pubmed-meshheading:17894765... | lld:pubmed |
pubmed-article:17894765 | pubmed:meshHeading | pubmed-meshheading:17894765... | lld:pubmed |
pubmed-article:17894765 | pubmed:meshHeading | pubmed-meshheading:17894765... | lld:pubmed |
pubmed-article:17894765 | pubmed:meshHeading | pubmed-meshheading:17894765... | lld:pubmed |
pubmed-article:17894765 | pubmed:meshHeading | pubmed-meshheading:17894765... | lld:pubmed |
pubmed-article:17894765 | pubmed:meshHeading | pubmed-meshheading:17894765... | lld:pubmed |
pubmed-article:17894765 | pubmed:meshHeading | pubmed-meshheading:17894765... | lld:pubmed |
pubmed-article:17894765 | pubmed:meshHeading | pubmed-meshheading:17894765... | lld:pubmed |
pubmed-article:17894765 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17894765 | pubmed:articleTitle | Adverse effects of a multicentre system for ethics approval on the progress of a prospective multicentre trial of cancer treatment: how many patients die waiting? | lld:pubmed |
pubmed-article:17894765 | pubmed:affiliation | East Coast Cancer Centre, Gold Coast, Queensland, Australia. dchristie@wesley.com.au | lld:pubmed |
pubmed-article:17894765 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17894765 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:17894765 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17894765 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17894765 | lld:pubmed |